NFKB1 and ovarian carcinoma: To functionally validate these findings, we evaluated the effects of stearidonic acid (SDA), a plant-derived omega-3 fatty acid with known NF-κB inhibitory properties 22, in combination with cisplatin in resistant ovarian cancer cell lines.